Novo Holdings A/S as of March 31, 2020
Portfolio Holdings for Novo Holdings A/S
Novo Holdings A/S holds 30 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Vanguard Total Stock Market ETF (VTI) | 49.8 | $746M | 5.8M | 128.91 | |
Inogen (INGN) | 12.2 | $183M | 3.5M | 51.66 | |
Cable One (CABO) | 8.2 | $123M | 75k | 1644.01 | |
Apple (AAPL) | 6.9 | $104M | 408k | 254.29 | |
Brookfield Asset Management | 4.0 | $60M | 2.0M | 29.50 | |
Morphic Hldg (MORF) | 2.6 | $39M | 2.6M | 14.68 | |
Mirum Pharmaceuticals (MIRM) | 2.3 | $34M | 2.4M | 14.00 | |
Galera Therapeutics (GRTX) | 2.2 | $32M | 3.4M | 9.50 | |
Akebia Therapeutics (AKBA) | 1.7 | $26M | 3.4M | 7.58 | |
Amicus Therapeutics (FOLD) | 1.4 | $21M | 2.3M | 9.24 | |
Seaspine Holdings | 0.9 | $14M | 1.7M | 8.17 | |
Blueprint Medicines (BPMC) | 0.9 | $14M | 234k | 58.48 | |
Si-bone (SIBN) | 0.8 | $12M | 971k | 11.95 | |
Aerie Pharmaceuticals | 0.7 | $10M | 751k | 13.50 | |
Inspire Med Sys (INSP) | 0.6 | $9.3M | 155k | 60.28 | |
Spero Therapeutics (SPRO) | 0.5 | $7.5M | 931k | 8.08 | |
Myokardia | 0.5 | $7.1M | 152k | 46.88 | |
Corvus Pharmaceuticals (CRVS) | 0.4 | $6.2M | 2.9M | 2.11 | |
Silk Road Medical Inc Common | 0.4 | $5.9M | 186k | 31.48 | |
Entasis Therapeutics Holdings Ord | 0.4 | $5.8M | 2.2M | 2.64 | |
Zogenix | 0.4 | $5.5M | 223k | 24.73 | |
Constellation Pharmceticls I | 0.4 | $5.3M | 168k | 31.43 | |
Flexion Therapeutics convertible security | 0.3 | $5.1M | 643k | 7.87 | |
Protagonist Therapeutics (PTGX) | 0.3 | $4.9M | 698k | 7.06 | |
Intersect Ent | 0.3 | $4.4M | 371k | 11.85 | |
Milestone Pharmaceuticals (MIST) | 0.3 | $3.8M | 2.1M | 1.84 | |
Verona Pharma Plc ads (VRNA) | 0.2 | $3.1M | 741k | 4.12 | |
Crinetics Pharmaceuticals In (CRNX) | 0.2 | $2.4M | 165k | 14.70 | |
Biohaven Pharmaceutical Holding | 0.1 | $1.8M | 54k | 34.03 | |
Neuronetics (STIM) | 0.1 | $1.7M | 903k | 1.89 |